The TCR-triggered activation by anti-CD3 and anti-CD28 antibodies induced a strong and significant increase of PD-1 as well as PD-L1 expression on CD4+ and CD8+ T cells from HNSCC patients, which were comparable to healthy donors. The gene discussed is CD4; the disease is head and neck squamous cell carcinoma.